Nasiri Aliakbar, Farajzadeh Vajari Farzad, Sane Shahryar, Afsargharehbagh Roghaiyeh
Department of Anesthesiology, Faculty of Medicine, University of Medical Sciences, Urmia, Iran.
Department of Cardilogy, School of Medicine, Urmia University of Medical Sciences, Urmia, Iran.
Anesth Pain Med. 2024 Mar 7;14(2):e142137. doi: 10.5812/aapm-142137. eCollection 2024 Apr.
The ganglion impar block is a minimally invasive technique used for alleviating pain associated with coccydynia.
This research evaluates the effectiveness of the ganglion impar block in treating patients with coccydynia who have not benefited from conservative treatments.
This cross-sectional analysis reviewed the clinical records of coccydynia patients who received ganglion impar block injections at Urmia Imam Khomeini Hospital, Urmia, Iran, between 2020 and 2022. Data regarding age, gender, body mass index (BMI), onset of pain, and levels of patient satisfaction post-treatment were gathered from the medical records.
The study comprised 26 patients, with 4 (15.4%) being male and 22 (84.6%) female. The average age and BMI were 39.15 ± 14.24 years and 28.91 ± 2.14 kg/m, respectively, which did not show significant variation (P = 0.19). The average Visual Analogue Scale (VAS) score before the ganglion impar block was 6.23 ± 2.35, which reduced to 4.47 ± 2.41 immediately after the procedure. At the 1-month follow-up, the average VAS score had further decreased to 3.47 ± 0.79. The decrease in VAS scores, both immediately after the procedure and at the 1-month follow-up, was statistically significant. The success rate of the block (defined as a reduction in pain of at least 20% from the baseline) was significantly high immediately and one-month post-procedure (P < 0.001). Out of the 26 patients treated with the impar block, satisfaction rates were 42.3% excellent, 27% good, 19.2% fair, and 11.5% poor.
The study endorses the trans-sacro-coccygeal "needle inside needle" method for providing relief to patients suffering from coccydynia. The findings revealed significant patient satisfaction, with the majority describing their experience as excellent.
奇神经节阻滞是一种用于缓解尾骨痛相关疼痛的微创技术。
本研究评估奇神经节阻滞对未从保守治疗中获益的尾骨痛患者的治疗效果。
本横断面分析回顾了2020年至2022年期间在伊朗乌尔米耶伊玛目霍梅尼医院接受奇神经节阻滞注射的尾骨痛患者的临床记录。从病历中收集了有关年龄、性别、体重指数（BMI）、疼痛发作情况以及治疗后患者满意度水平的数据。
该研究包括26例患者，其中男性4例（15.4%），女性22例（84.6%）。平均年龄和BMI分别为39.15±14.24岁和28.91±2.14kg/m²，差异无统计学意义（P = 0.19）。奇神经节阻滞前视觉模拟量表（VAS）平均评分为6.23±2.35，术后立即降至4.47±2.41。在1个月随访时，VAS平均评分进一步降至3.47±0.79。术后立即及1个月随访时VAS评分的降低具有统计学意义。阻滞成功率（定义为疼痛较基线至少降低20%）在术后立即及1个月时显著较高（P < 0.001）。在接受奇神经节阻滞治疗的26例患者中，满意度为优秀的占42.3%，良好的占27%，中等的占19.2%，差的占11.5%。
该研究支持经骶尾“针内针”方法为尾骨痛患者提供缓解。研究结果显示患者满意度较高，大多数患者将其体验描述为优秀。
